Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Poster Session I - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.02 - GENETICS, OMICS AND BIOMARKERS P480 - ESOC25-1882 CIRCULATING LNCRNAS AS POTENTIAL BIOMARKERS OF HAEMATOMA GROWTH IN INTRACEREBRAL HAEMORRHAGE: A PILOT STUDY Maria Lucas-Parra 1 , Carme Gubern-Mrida 1 , Carla Herminia Vera Caceres 2 , Dolors Puigoriol Illamola 1 , Laia Carballo-Perich 1 , Mikel Terceo 3 , Saima Bashir Viturro 1,2 , Toms Xucl-Ferrarons 1,2 , Vctor Vera-Monge 2 , Alan Murillo 2 , Juan Alvarez-Cienfuegos 1,2 , Isabel Vielba 2 , Elisabet Ortiz Martos 2 , Joaquin Serena 1,2 , Yolanda Silva 1,2 1 Institut dInvestigaci Biomdica de Girona (IDIBGI), Cerebrovascular Pathology group, Salt, Spain, 2 Hospital Universitari Dr
Alma Skin, Pistactive Fusion (Italy) Italian biotech start-up Alma Skin introduced its patented Pistactive Fusion platform to the U.S
The reaction is more pronounced under certain specific conditions
Its also not recommended for older adults
Schilrreff P, Alexiev U
